{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:07:50Z","timestamp":1790446070289,"version":"4.1.0"},"reference-count":48,"publisher":"American Society of Hematology","issue":"20","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,11,17]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Obesity and inflammatory bowel disease (IBD) are systemic inflammatory disorders that predispose to arterial and venous thrombosis through similar prothrombotic mechanisms. Obesity and IBD are chronic risk factors that lead to a persistently elevated risk of thrombosis, although the thrombotic risk with IBD appears to wax and wane with disease severity. Because of the lack of high-quality evidence to guide management decisions, approaches to the prevention and treatment of thrombosis in patients with obesity or IBD are based on extrapolation from general guidelines for antithrombotic therapy. Obesity alters the pharmacokinetics of some anticoagulant drugs, and IBD patients present the added management challenge of having a high risk of gastrointestinal bleeding while taking anticoagulants. An extended duration of anticoagulant therapy is often recommended for obese or IBD patients with unprovoked venous thromboembolism unless there is a high risk of bleeding, although more data and better biomarkers are needed to determine whether anticoagulation can be safely stopped in a subset of IBD patients during remission of active disease. Most patients with obesity or IBD require thromboprophylaxis in conjunction with hospitalization or surgery, with adjustment of anticoagulant dosing in patients with severe obesity.<\/jats:p>","DOI":"10.1182\/blood-2016-05-716720","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T17:40:28Z","timestamp":1479404428000},"page":"2388-2394","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":50,"title":["Thrombosis in the setting of obesity or inflammatory bowel disease"],"prefix":"10.1182","volume":"128","author":[{"given":"Steven R.","family":"Lentz","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, The University of Iowa Carver College of Medicine, Iowa City, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"1","key":"2019111905152513700_B1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0034-1398376","article-title":"Coagulation in patients with severe sepsis","volume":"41","author":"Levi","year":"2015","journal-title":"Semin Thromb Hemost"},{"issue":"9","key":"2019111905152513700_B2","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/CIRCRESAHA.116.306853","article-title":"Cross talk pathways between coagulation and inflammation","volume":"118","author":"Foley","year":"2016","journal-title":"Circ Res"},{"issue":"5","key":"2019111905152513700_B3","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/MOH.0b013e3283634443","article-title":"Mechanisms of thrombosis in obesity","volume":"20","author":"Blokhin","year":"2013","journal-title":"Curr Opin Hematol"},{"issue":"6","key":"2019111905152513700_B4","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1160\/TH14-06-0563","article-title":"Epidemiology and pathophysiology of venous thromboembolism: similarities with atherothrombosis and the role of inflammation","volume":"113","author":"Riva","year":"2015","journal-title":"Thromb Haemost"},{"key":"2019111905152513700_B5","article-title":"Obesity and Overweight","author":"World Health Organization: World Health Organization Fact Sheet N311","year":"2013"},{"issue":"1","key":"2019111905152513700_B6","first-page":"e6","article-title":"Heart disease and stroke statistics\u2013;2013 update: a report from the American Heart Association","volume":"127","author":"Go","year":"2013","journal-title":"Circulation"},{"issue":"9497","key":"2019111905152513700_B7","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/S0140-6736(05)67663-5","article-title":"Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study","volume":"366","author":"Yusuf","year":"2005","journal-title":"Lancet"},{"issue":"7","key":"2019111905152513700_B8","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1161\/01.STR.0000075294.98582.2F","article-title":"Abdominal obesity and risk of ischemic stroke: the Northern Manhattan Stroke Study","volume":"34","author":"Suk","year":"2003","journal-title":"Stroke"},{"issue":"15","key":"2019111905152513700_B9","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1161\/CIRCULATIONAHA.111.063354","article-title":"Body mass index, surgery, and risk of venous thromboembolism in middle-aged women: a cohort study","volume":"125","author":"Parkin","year":"2012","journal-title":"Circulation"},{"issue":"1","key":"2019111905152513700_B10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/CIRCULATIONAHA.107.709204","article-title":"Cardiovascular risk factors and venous thromboembolism: a meta-analysis","volume":"117","author":"Ageno","year":"2008","journal-title":"Circulation"},{"issue":"10","key":"2019111905152513700_B11","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1001\/archinte.162.10.1182","article-title":"Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology","volume":"162","author":"Tsai","year":"2002","journal-title":"Arch Intern Med"},{"issue":"15","key":"2019111905152513700_B12","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1001\/archinte.168.15.1678","article-title":"Overweight, obesity, and the risk of recurrent venous thromboembolism","volume":"168","author":"Eichinger","year":"2008","journal-title":"Arch Intern Med"},{"issue":"12","key":"2019111905152513700_B13","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1182\/blood-2013-12-512681","article-title":"Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism","volume":"123","author":"Kearon","year":"2014","journal-title":"Blood"},{"issue":"5","key":"2019111905152513700_B14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1503\/cmaj.080493","article-title":"Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy","volume":"179","author":"Rodger","year":"2008","journal-title":"CMAJ"},{"issue":"1","key":"2019111905152513700_B15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1152\/physrev.00033.2011","article-title":"Pathophysiology of human visceral obesity: an update","volume":"93","author":"Tchernof","year":"2013","journal-title":"Physiol Rev"},{"issue":"20","key":"2019111905152513700_B16","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1182\/blood-2013-05-427708","article-title":"Inflammation, obesity, and thrombosis","volume":"122","author":"Samad","year":"2013","journal-title":"Blood"},{"issue":"8","key":"2019111905152513700_B17","first-page":"CD003641","article-title":"Surgery for weight loss in adults","author":"Colquitt","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"2019111905152513700_B18","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1111\/j.1538-7836.2010.04044.x","article-title":"A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score","volume":"8","author":"Barbar","year":"2010","journal-title":"J Thromb Haemost"},{"key":"2019111905152513700_B19","author":"Kahn","year":"2012"},{"issue":"2-3","key":"2019111905152513700_B20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.disamonth.2005.02.003","article-title":"Thrombosis risk assessment as a guide to quality patient care","volume":"51","author":"Caprini","year":"2005","journal-title":"Dis Mon"},{"key":"2019111905152513700_B21","author":"Gould","year":"2012"},{"issue":"2","key":"2019111905152513700_B22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"issue":"2","key":"2019111905152513700_B23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jcrc.2014.11.020","article-title":"Unfractionated heparin dosing for therapeutic anticoagulation in critically ill obese adults","volume":"30","author":"Hohner","year":"2015","journal-title":"J Crit Care"},{"issue":"1","key":"2019111905152513700_B24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1160\/TH13-01-0042","article-title":"Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatients","volume":"111","author":"Wang","year":"2014","journal-title":"Thromb Haemost"},{"key":"2019111905152513700_B25","author":"Garcia","year":"2012"},{"issue":"6","key":"2019111905152513700_B26","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1345\/aph.1L194","article-title":"Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings","volume":"43","author":"Nutescu","year":"2009","journal-title":"Ann Pharmacother"},{"issue":"1","key":"2019111905152513700_B27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4212\/cjhp.v68i1.1423","article-title":"Measuring anti-factor xa activity to monitor low-molecular-weight heparin in obesity: a critical review","volume":"68","author":"Egan","year":"2015","journal-title":"Can J Hosp Pharm"},{"issue":"9","key":"2019111905152513700_B28","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1161\/CIRCRESAHA.116.306925","article-title":"Evolving Treatments for Arterial and Venous Thrombosis: Role of the Direct Oral Anticoagulants","volume":"118","author":"Chan","year":"2016","journal-title":"Circ Res"},{"issue":"1","key":"2019111905152513700_B29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11239-015-1314-3","article-title":"Pharmacology of anticoagulants used in the treatment of venous thromboembolism","volume":"41","author":"Nutescu","year":"2016","journal-title":"J Thromb Thrombolysis"},{"issue":"8","key":"2019111905152513700_B30","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/MBC.0000000000000369","article-title":"Meta-analysis on efficacy and safety of new oral anticoagulants for venous thromboembolism prophylaxis in elderly elective postarthroplasty patients","volume":"26","author":"Pathak","year":"2015","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"12","key":"2019111905152513700_B31","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1182\/blood-2014-04-571232","article-title":"Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials","volume":"124","author":"van Es","year":"2014","journal-title":"Blood"},{"issue":"6","key":"2019111905152513700_B32","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/jth.13323","article-title":"Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH","volume":"14","author":"Martin","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2019111905152513700_B33","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/STROKEAHA.115.011876","article-title":"Body Mass Index and Adverse Outcomes in Elderly Patients With Atrial Fibrillation: The AMADEUS Trial","volume":"47","author":"Senoo","year":"2016","journal-title":"Stroke"},{"issue":"4","key":"2019111905152513700_B34","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s11239-015-1226-2","article-title":"Body mass index predicts major bleeding risks in patients on warfarin","volume":"40","author":"Ogunsua","year":"2015","journal-title":"J Thromb Thrombolysis"},{"issue":"5","key":"2019111905152513700_B35","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s11695-012-0854-2","article-title":"Pulmonary embolism and deep venous thrombosis following bariatric surgery","volume":"23","author":"Stein","year":"2013","journal-title":"Obes Surg"},{"key":"2019111905152513700_B36","first-page":"461","article-title":"Prevention of venous thromboembolism in patients undergoing bariatric surgery","volume":"11","author":"Bartlett","year":"2015","journal-title":"Vasc Health Risk Manag"},{"issue":"6","key":"2019111905152513700_B37","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/SLA.0b013e31825659d4","article-title":"Predicting risk for venous thromboembolism with bariatric surgery: results from the Michigan Bariatric Surgery Collaborative","volume":"255","author":"Finks","year":"2012","journal-title":"Ann Surg"},{"issue":"4","key":"2019111905152513700_B38","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.thromres.2014.01.021","article-title":"Efficacy and safety of weight-adjusted heparin prophylaxis for the prevention of acute venous thromboembolism among obese patients undergoing bariatric surgery: a systematic review and meta-analysis","volume":"133","author":"Ikesaka","year":"2014","journal-title":"Thromb Res"},{"issue":"4","key":"2019111905152513700_B39","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s00464-014-3746-9","article-title":"The efficacy of prophylactic IVC filters in gastric bypass surgery","volume":"29","author":"Wilhelm","year":"2015","journal-title":"Surg Endosc"},{"issue":"7","key":"2019111905152513700_B40","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/jamasurg.2013.72","article-title":"Pharmacologic and mechanical strategies for preventing venous thromboembolism after bariatric surgery: a systematic review and meta-analysis","volume":"148","author":"Brotman","year":"2013","journal-title":"JAMA Surg"},{"issue":"4","key":"2019111905152513700_B41","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.soard.2014.04.008","article-title":"Inferior vena cava filters and postoperative outcomes in patients undergoing bariatric surgery: a meta-analysis","volume":"10","author":"Kaw","year":"2014","journal-title":"Surg Obes Relat Dis"},{"key":"2019111905152513700_B42","author":"Nguyen","year":"2014"},{"issue":"9715","key":"2019111905152513700_B43","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(09)61963-2","article-title":"Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study","volume":"375","author":"Grainge","year":"2010","journal-title":"Lancet"},{"key":"2019111905152513700_B44","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2010.05.026","article-title":"Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism","author":"Novacek","year":"2010"},{"key":"2019111905152513700_B45","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2013.08.023","article-title":"Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis","author":"Singh","year":"2014"},{"issue":"6","key":"2019111905152513700_B46","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1080\/00365529850171927","article-title":"Markers of coagulation and fibrinolysis as measures of disease activity in inflammatory bowel disease","volume":"33","author":"Kjeldsen","year":"1998","journal-title":"Scand J Gastroenterol"},{"issue":"10","key":"2019111905152513700_B47","doi-asserted-by":"crossref","first-page":"e479","DOI":"10.1016\/j.crohns.2013.03.002","article-title":"Predictors and safety of venous thromboembolism prophylaxis among hospitalized inflammatory bowel disease patients","volume":"7","author":"Ra","year":"2013","journal-title":"J Crohn\u2019s Colitis"},{"issue":"5","key":"2019111905152513700_B48","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/MIB.0000000000000736","article-title":"Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative Colitis","volume":"22","author":"Theede","year":"2016","journal-title":"Inflamm Bowel Dis"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/128\/20\/2388\/1396862\/blood716720.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/128\/20\/2388\/1396862\/blood716720.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T18:22:26Z","timestamp":1749752546000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/128\/20\/2388\/35607\/Thrombosis-in-the-setting-of-obesity-or"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,17]]},"references-count":48,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2016,11,17]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-05-716720","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,17]]}}}